State-of-the-Art Smart and Intelligent Nanobiosensors for SARS-CoV-2 Diagnosis

Biosensors (Basel). 2022 Aug 13;12(8):637. doi: 10.3390/bios12080637.

Abstract

The novel coronavirus appeared to be a milder infection initially, but the unexpected outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), commonly called COVID-19, was transmitted all over the world in late 2019 and caused a pandemic. Human health has been disastrously affected by SARS-CoV-2, which is still evolving and causing more serious concerns, leading to the innumerable loss of lives. Thus, this review provides an outline of SARS-CoV-2, of the traditional tools to diagnose SARS-CoV-2, and of the role of emerging nanomaterials with unique properties for fabricating biosensor devices to diagnose SARS-CoV-2. Smart and intelligent nanomaterial-enabled biosensors (nanobiosensors) have already proven their utility for the diagnosis of several viral infections, as various detection strategies based on nanobiosensor devices are already present, and several other methods are also being investigated by researchers for the determination of SARS-CoV-2 disease; however, considerably more is undetermined and yet to be explored. Hence, this review highlights the utility of various nanobiosensor devices for SARS-CoV-2 determination. Further, it also emphasizes the future outlook of nanobiosensing technologies for SARS-CoV-2 diagnosis.

Keywords: COVID-19; SARS-CoV-2; biosensors; nanobiosensors; nanomaterials; smart and intelligent nanomaterials.

Publication types

  • Review

MeSH terms

  • Biosensing Techniques*
  • COVID-19 Testing
  • COVID-19* / diagnosis
  • Humans
  • Pandemics
  • SARS-CoV-2

Grants and funding

This review did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. This research received no external funding.